Purpose: Uveitis and scleritis are the most serious ocular side effects of bisphosphonate
therapy. The purpose of this study was to determine the 6-month rates of uveitis/scleritis …

Background: There have been several published reports of inflammatory ocular adverse
events, mainly uveitis and scleritis, among patients taking oral bisphosphonates. We …

Ocular inflammatory reactions have been described in patients on bisphosphonate
treatment. We estimated the incidence rate of ocular inflammation at 3 and 12 months in …

Bisphosphonates are used to inhibit bone resorption in postmenopausal women and in the
management of hypercalcemia of malignancy. Recently, some drugs within this class of …

Background/Aims: To highlight the potential ocular side effects of bisphosphonate therapy
and the importance of a proper drug history in patients who present with uveitis. Methods …

Discussion Cases of ocular inflammation in patients taking bisphosphonates have been
reported since the early 1990s. 5, 6 Cases have involved both nitrogen and non-nitrogen …

PURPOSE: To investigate the incidence of significant adverse ocular side effects after
intravenous zoledronate infusion for osteopenia. DESIGN: Data analysis of a large …

In rare cases, bisphosphonates are well established to cause ocular inflammation,
presenting as uveitis, episcleritis, scleritis, orbital inflammation, and/or conjunctivitis. Some …

Bisphosphonates are becoming more widespread as indications for them broaden. Several
ocular side effects due to bisphosphonates have been described, among the most …

An 86-year-old female was treated for osteoporosis with alendronate, an
aminobisphosphonate. Six weeks after alendronate therapy began, scleritis developed in …